Completed

Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Clinicaltrials.gov Identifier: 

nct02277743

Trial details

Trial date:
October 2014 - November 2015
Phase:  3
Birth sex
Male and female gender symbols.
Age range
18 Years and Older
Accepts healthy volunteers
No
Condition(s) being studied: 

Dermatitis, Atopic

What is the type of trial? 

Interventional

What is the trial testing? 

Dupilumab, Placebo (for Dupilumab)

How many people are being enrolled? 

671

Trial summary

This is a randomized, double-blind, placebo-controlled, parallel group study to confirm the efficacy and safety of Dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis (AD).

Trial locations

0 location(s)